AXYNC, created in 2003 (Netherlands), from
402 sister brands
and 17477 competing brands.
The AXYNC brand is owned by Merck & Co, a company listed in New York.
AXYNC is part of the Drug Manufacturers activity sector.
Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.